GO:0031519 PcG protein complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031519 (PcG protein complex) is a chromatin-associated multiprotein complex containing Polycomb Group proteins that maintains long-term gene repression.
• The complex is defined by its association with Polycomb group response elements (PREs) and its role in regulating higher-order chromatin structure.
• Core enzymatic activity includes histone H3 lysine 27 methylation by the PRC2 subunit EZH2, a hallmark of Polycomb silencing.
• PcG complexes are context-specific in development and cancer, with distinct subunit compositions driving different target gene sets.
• Dysregulation of PcG proteins is linked to poor survival in cancers such as salivary gland adenoid cystic carcinoma and to AML through fusion protein antagonism.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential for dissecting PcG complex function in disease.
Description
The PcG protein complex (GO:0031519) is a chromatin-associated multiprotein assembly containing Polycomb Group proteins, which are best known for maintaining long-term gene repression in Drosophila and mammals. These complexes bind to Polycomb group response elements (PREs) in target genes and regulate higher-order chromatin structure, thereby establishing heritable epigenetic states that control developmental gene expression programs. Understanding GO:0031519 is critical because its components are frequently mutated or overexpressed in human cancers and developmental disorders, making it a prime target for mechanistic and therapeutic research. Researchers study this complex to uncover how epigenetic memory is propagated and how its disruption contributes to disease, using tools such as CRISPR screens, proteomics, and chromatin profiling.
PcG protein complex At A Glance
| GO ID | GO:0031519 |
|---|---|
| GO term | PcG protein complex |
| Ontology | cellular_component |
| Synonym | Polycomb Group protein complex |
| Major function | Long-term maintenance of gene repression and regulation of higher-order chromatin structure |
| Associated elements | Polycomb group response elements (PREs) in target genes |
| Key enzymatic activity | Histone H3 lysine 27 methylation by PRC2 subunit EZH2 |
| Context specificity | Subunit composition and target genes vary by developmental stage and tissue |
What Is GO:0031519?
GO:0031519, the PcG protein complex, is defined by QuickGO as a chromatin-associated multiprotein complex containing Polycomb Group proteins. In Drosophila, Polycomb group proteins are involved in the long-term maintenance of gene repression, and PcG protein complexes associate with Polycomb group response elements (PREs) in target genes to regulate higher-order chromatin structure. This definition emphasizes the complex's role as a repressive chromatin modifier that maintains gene silencing across cell divisions.
Why Is PcG protein complex Important in Cell Biology?
The PcG protein complex is essential for epigenetic memory and developmental gene regulation, and its dysfunction is increasingly recognized as a driver of cancer and other diseases. Because it maintains gene repression over many cell divisions, it serves as a paradigm for understanding chromatin-based inheritance and offers a rich source of therapeutic targets.
• Maintains long-term gene repression critical for cell fate decisions.
• Regulates higher-order chromatin structure through PRE binding.
• EZH2 overexpression predicts poor survival in salivary gland adenoid cystic carcinoma.
• NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML.
• Context-specific Polycomb mechanisms influence development and cancer progression.
• Serves as a model for epigenetic inheritance and chromatin regulation.
• Provides targets for epigenetic therapies in oncology.
• Involved in Polycomb group protein polyhomeotic mechanisms beyond SAM.
• Essential for understanding developmental gene expression programs.
• Enables CRISPR-based functional studies of chromatin regulators.
What Happens During PcG protein complex?
Recruitment to Polycomb group response elements (PREs)
In simple terms: The complex finds specific DNA landing pads called PREs to start silencing genes.
PcG protein complexes associate with Polycomb group response elements (PREs) in target genes to initiate repression. This recruitment is a prerequisite for the long-term maintenance of gene repression observed in Drosophila and mammals.
Histone H3 lysine 27 methylation by PRC2
In simple terms: A key enzyme in the complex adds a chemical mark to histones that signals 'silence this gene'.
The PRC2 subunit EZH2 catalyzes histone H3 lysine 27 methylation, a hallmark of Polycomb-group silencing. This methylation creates a binding platform for PRC1 and reinforces the repressed chromatin state.
Higher-order chromatin compaction
In simple terms: The complex compacts DNA into a tight structure that blocks gene activation.
PcG protein complexes regulate higher-order chromatin structure, leading to a compacted state that is refractory to transcription. This structural change is central to the stable repression of developmental genes.
Context-specific targeting and gene repression
In simple terms: The complex chooses different genes to silence depending on the cell type and stage.
Context-specific Polycomb mechanisms in development determine which genes are repressed, with subunit composition influencing target selection. This specificity is crucial for proper differentiation and is often dysregulated in cancer.
Key Genes Involved in GO:0031519 PcG protein complex
The following genes encode core and accessory components of the PcG protein complex, each with distinct roles in assembly, catalysis, and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EZH2 | Catalytic subunit of PRC2; methylates H3K27 | Overexpressed in cancers; predicts poor survival |
| EED | PRC2 subunit; binds methylated H3K27 | Allosteric activation of EZH2; cancer target |
| SUZ12 | PRC2 subunit; essential for complex integrity | Required for H3K27 methylation and silencing |
| RBBP4 | PRC2 subunit; histone chaperone | Facilitates nucleosome binding |
| RBBP7 | PRC2 subunit; histone chaperone | Paralog of RBBP4; redundant functions |
| AEBP2 | PRC2 accessory factor | Modulates PRC2 activity and targeting |
| JARID2 | PRC2 accessory factor | Recruits PRC2 to target genes |
| PHC1 | PRC1 subunit; chromatin compaction | Polyhomeotic homolog; SAM domain function |
| PHC2 | PRC1 subunit; chromatin compaction | Polyhomeotic homolog; SAM domain function |
| BMI1 | PRC1 subunit; ring finger protein | Monoubiquitinates H2AK119; cancer stem cell maintenance |
| RING1 | PRC1 catalytic subunit | Monoubiquitinates H2AK119 |
| RNF2 | PRC1 catalytic subunit | Monoubiquitinates H2AK119 |
| CBX2 | PRC1 subunit; binds H3K27me3 | Links PRC2 and PRC1 |
| CBX4 | PRC1 subunit; binds H3K27me3 | SUMOylation and recruitment |
| CBX6 | PRC1 subunit; binds H3K27me3 | Context-dependent repression |
| CBX7 | PRC1 subunit; binds H3K27me3 | Involved in stem cell maintenance |
| KDM2B | Recruits PRC1 to CpG islands | Alternative PRC1 targeting |
How Is PcG protein complex Regulated?
The PcG protein complex is regulated at multiple levels, including post-translational modifications of subunits, interaction with non-coding RNAs, and antagonism by activating complexes. For example, NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML, highlighting how disruption of PcG repression can lead to oncogenic transcription. Additionally, Mdm2 has been described as a chromatin modifier that may influence Polycomb-mediated repression. Context-specific mechanisms further modulate PcG activity during development and disease.
PcG protein complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Salivary gland adenoid cystic carcinoma; poor survival | Knockout and overexpression in cancer cell lines |
| NUP98 | Acute myeloid leukemia (AML) | Knock-in fusion models and PRC1.1 antagonism studies |
| KMT2A | AML with KMT2A-MENIN antagonism | CRISPR knockout and point mutation of MENIN interaction domain |
| BMI1 | Cancer stem cell maintenance | Knockout and overexpression in stem cell models |
| PHC1 | Polyhomeotic-related functions | Point mutation of SAM domain to study polymerization |
Cancer
Dysregulation of PcG protein complex components is frequent in cancer. High expression of EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. In acute myeloid leukemia, NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression, underscoring the role of PcG complexes in leukemogenesis. The roles of Polycomb repressive complexes in mammalian development and cancer are well documented.
Developmental disorders
Because PcG complexes maintain gene repression programs essential for development, their disruption can lead to developmental abnormalities. Context-specific Polycomb mechanisms are critical for proper differentiation, and mutations in core subunits can cause severe developmental phenotypes.
Epigenetic regulation in disease
Epigenetic regulation by Polycomb group proteins is a broad area of disease research, with implications for cancer, stem cell biology, and inherited disorders. The complex's ability to maintain long-term repression makes it a key player in pathological gene silencing.
From PcG protein complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EZH2 loss abolish H3K27 methylation? | EZH2 knockout cell lines |
| How does a point mutation in EZH2 affect catalytic activity? | Point mutation knock-in of EZH2 catalytic domain |
| Can PRC1.1 antagonism drive AML gene expression? | Knock-in of NUP98 fusion proteins |
| What is the role of PHC1 SAM domain polymerization? | Point mutation or tagged knock-in of PHC1 |
| Does overexpression of EZH2 promote tumor growth? | Overexpression models in cancer cell lines |
| How does BMI1 contribute to stem cell maintenance? | Knockout and overexpression in stem cells |
How to Study the PcG protein complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding of PcG subunits and H3K27me3 | Mapping PREs and repressed chromatin |
| Mass spectrometry | Subunit composition and interactors | Identifying context-specific complexes |
| RNA-seq | Gene expression changes | Measuring derepression upon knockout |
| CRISPR knockout screens | Gene essentiality and modifier identification | Finding synthetic lethal targets |
| Western blot | Protein levels of EZH2, SUZ12, etc. | Validating knockout or overexpression |
| Immunofluorescence | Nuclear localization and chromatin compaction | Visualizing PcG bodies |
| ATAC-seq | Chromatin accessibility | Assessing higher-order chromatin changes |
| Co-immunoprecipitation | Physical interactions between subunits | Validating complex assembly |
Chromatin immunoprecipitation (ChIP)
ChIP followed by sequencing (ChIP-seq) is used to map binding of PcG complex subunits to PREs and to measure H3K27me3 marks across the genome.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry identifies subunit composition and context-specific interactors of the PcG protein complex.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes that modify PcG complex function or resistance to epigenetic therapies.
Transcriptomics
RNA-seq measures changes in gene expression upon PcG complex perturbation, revealing derepressed target genes.
How CRISPR Can Be Used to Study GO:0031519 PcG protein complex
Knockout
CRISPR knockout of core PcG genes such as EZH2, SUZ12, or BMI1 abolishes complex function, leading to loss of H3K27 methylation and derepression of target genes. These models are used to study the dependency of cancer cells on Polycomb silencing.
Point Mutation
Point mutations in catalytic residues of EZH2 or in the SAM domain of PHC1 can dissect specific functions without disrupting complex assembly. Such models help distinguish catalytic activity from scaffolding roles.
Knock-in
Knock-in of fusion proteins such as NUP98 fusions or tagged subunits allows tracking of complex dynamics and studying oncogenic mechanisms in AML. Tagged knock-in of PHC1 enables imaging of polymerization in live cells.
Overexpression
Overexpression of EZH2 or BMI1 in cancer cell lines models the gain-of-function observed in tumors and allows testing of targeted inhibitors. These models are valuable for preclinical drug evaluation.
How EDITGENE Supports PcG protein complex Research
Researchers studying PcG protein complex-related genes often need to determine whether a candidate gene is causally involved in gene repression, chromatin compaction, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for PcG protein complex research.
Frequently Asked Questions About PcG protein complex
What is GO:0031519?
GO:0031519 is the Gene Ontology term for the PcG protein complex, a chromatin-associated multiprotein complex containing Polycomb Group proteins that maintains long-term gene repression.
What genes are involved in the PcG protein complex?
Core genes include EZH2, EED, SUZ12, RBBP4, RBBP7, AEBP2, JARID2, BMI1, RING1, RNF2, and CBX family members.
What is the function of the PcG protein complex?
It maintains long-term gene repression by associating with Polycomb group response elements and regulating higher-order chromatin structure.
How is the PcG protein complex linked to cancer?
Overexpression of EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma, and NUP98 fusions antagonize PRC1.1 in AML.
What is the role of EZH2 in the PcG protein complex?
EZH2 is the catalytic subunit of PRC2 that methylates histone H3 lysine 27, a hallmark of Polycomb silencing.
How do researchers study the PcG protein complex?
Common methods include ChIP-seq, mass spectrometry, RNA-seq, and CRISPR screens to map binding, composition, and function.
What are Polycomb group response elements?
PREs are DNA sequences in target genes where PcG protein complexes bind to initiate and maintain repression.
Can CRISPR be used to study PcG protein complex function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect PcG complex roles in disease.
What diseases are associated with PcG protein complex dysfunction?
Cancers such as adenoid cystic carcinoma and AML, as well as developmental disorders, are linked to PcG dysregulation.
What is the difference between PRC1 and PRC2?
PRC2 catalyzes H3K27 methylation via EZH2, while PRC1 recognizes H3K27me3 and compacts chromatin through subunits like BMI1 and RING1.
Conclusion
The PcG protein complex (GO:0031519) is a central epigenetic regulator that maintains gene repression and shapes chromatin architecture. Its context-specific functions in development and cancer make it a high-priority target for mechanistic studies and therapeutic intervention. Leveraging CRISPR-based models and multi-omics approaches will continue to unravel its complex biology and disease relevance.
References
- 1. Cao R et al.. 2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.. Science 298(5595):1039-43 PMID: 12351676
- 2. Wienken M et al.. 2017. Mdm2 as a chromatin modifier.. J Mol Cell Biol 9(1):74-80 PMID: 27927750
- 3. Minarovits J et al.. 2016. Epigenetic Regulation.. Adv Exp Med Biol 879:1-25 PMID: 26659261
- 4. Kim JJ et al.. 2022. Context-specific Polycomb mechanisms in development.. Nat Rev Genet 23(11):680-695 PMID: 35681061
- 5. Vékony H et al.. 2008. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.. J Clin Pathol 61(6):744-9 PMID: 18326020
- 6. Heikamp EB et al.. 2024. NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML.. Cell Rep 43(11):114901 PMID: 39475509
- 7. Piunti A et al.. 2021. The roles of Polycomb repressive complexes in mammalian development and cancer.. Nat Rev Mol Cell Biol 22(5):326-345 PMID: 33723438
- 8. Pal N et al.. 2026. More than SAM: mechanisms of action of the Polycomb group protein polyhomeotic.. Nucleus 17(1):2709920 PMID: 42549674
